AstraZeneca and the Artery Explorer Take California Residents on Virtual Journey Through th... (ulatory system as the arteries become na...)

AstraZeneca and the Artery Explorer Take California Residents on Virtual Journey Through the Arteries

Date:7/31/2009

ulatory system as the arteries become narrow and blocked with plaque. Along the way, they will confront common risk factors for athero, such as LDL (bad) cholesterol, high blood pressure, and smoking. The experience concludes with a head-on collision with a blood clot, demonstrating how athero can result in a heart attack or stroke.

Atherosclerosis can begin in early adulthood and may continue as a person ages(5), making it especially important for the senior population to understand their risk factors. By allowing people to experience this otherwise silent disease, the Artery Explorer will educate attendees at the 2009 Senior Games about atherosclerosis and encourage them to take steps to take care of their arteries.

"As a proud national sponsor of both the US AGAINST ATHERO movement and the 2009 Senior Games, AstraZeneca has a commitment that goes beyond research and includes early detection and patient education programs," said Anne Blackwood, Associate Director of Government Affairs, AstraZeneca Pharmaceuticals LP, US. "We've brought these two programs together to help make a difference for Senior Games athletes and their families by encouraging them to become advocates for their own health and to take action."

Since its 2008 launch, the US AGAINST ATHERO campaign has educated over 100 million Americans about preventing and managing atherosclerosis. In 2009, the Artery Explorer will visit 16 major cities across the US. At the 2009 Senior Games, the Artery Explorer will be situated on the Stanford University campus in Palo Alto, Calif. Attendees can also visit the main AstraZeneca display in the Athlete Village. For people who can't visit the Artery Explorer in person, a video is available at www.athero.com, in addition to more information about atherosclerosis and an opportunity to enroll in the educational Athero IQ program.

'/>"/>

0

GOOD

Page: 1 2 3 4 5
Related medicine news :

1. AstraZeneca Leads Local Walking Movement
2. AstraZeneca Joins Local Walking Movement
3. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
4. Verus Pharmaceuticals Announces Divestiture of Pediatric Asthma Development Programs to AstraZeneca
5. AstraZeneca Recognized as One of Working Mothers 100 Best Companies for the Sixth Consecutive Year
6. AstraZeneca Launches New Program to Support Facilities that Connect People to Needed Medical Care and Prescription Assistance
7. NPS Sells Assets Related to mGluR Collaboration to AstraZeneca for $30 Million to Support Late-Stage Product Development
8. Everett-Area Cancer Patients Can More Easily Navigate Health Care System Thanks to the American Cancer Society and AstraZeneca
9. Perrigo Announces that Dexcels Settlement with AstraZeneca Allows OTC Omeprazole Launch Following Final FDA Approval
10. AstraZeneca Response to November 2, 2007 Ruling In Re: Pharmaceutical Industry Average Wholesale Price Litigation, MDL No. 1456, U.S. District Court, District of Massachusetts
11. AstraZeneca Receives Six Months Pediatric Exclusivity Patent Extension for ARIMIDEX(R) (anastrozole) from the FDA

Post Your Comments:

AstraZeneca and the Artery Explorer Take California Residents on Virtual Journey Through th...(ulatory system as the arteries become na...),Health